Stada Names Novartis Exec as New CEO, It's Fifth Leader Since 2016 Post author:Sam Post published:January 31, 2018 Post category:BioPharma Today STADA announced the appointment of Peter Goldschmidt as new CEO and chairman of the board. Source: BioSpace You Might Also Like New Kid on the Block Provention Bio Snags 2 Clinic-Ready Immune Compounds From Johnson & Johnson September 20, 2017 Diffusion Pharma Names Chief Business Officer August 22, 2017 J&J, Sanofi Top Bioethics International Transparency Report December 12, 2017
New Kid on the Block Provention Bio Snags 2 Clinic-Ready Immune Compounds From Johnson & Johnson September 20, 2017